263 related articles for article (PubMed ID: 15458436)
1. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
[TBL] [Abstract][Full Text] [Related]
2. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
4. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
[TBL] [Abstract][Full Text] [Related]
6. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
[TBL] [Abstract][Full Text] [Related]
7. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
8. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
[TBL] [Abstract][Full Text] [Related]
9. FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.
Ni HF; Chen JF; Zhang MH; Pan MM; Zhang JD; Liu H; Tang RN; Ma KL; Liu BC
Ren Fail; 2013 Aug; 35(7):996-1004. PubMed ID: 23848241
[TBL] [Abstract][Full Text] [Related]
10. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
[TBL] [Abstract][Full Text] [Related]
11. [Effect of FTY720 on glomerulosclerosis and expression of cell cycle regulatory proteins in subtotally nephrectomized rats].
Zhu GQ; Zhou JH; Xie M; Hao Y
Zhonghua Er Ke Za Zhi; 2007 Dec; 45(12):922-6. PubMed ID: 18339282
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
[TBL] [Abstract][Full Text] [Related]
13. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
[TBL] [Abstract][Full Text] [Related]
14. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis.
Krämer S; Kron S; Wang-Rosenke Y; Loof T; Khadzhynov D; Morgera S; Kawachi H; Shimizu F; Martini S; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F801-11. PubMed ID: 18216152
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the rat.
Wang-Rosenke Y; Khadzhynov D; Loof T; Mika A; Kawachi H; Neumayer HH; Peters H
BMC Nephrol; 2013 Oct; 14():223. PubMed ID: 24119229
[TBL] [Abstract][Full Text] [Related]
17. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
[TBL] [Abstract][Full Text] [Related]
18. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
[TBL] [Abstract][Full Text] [Related]
19. FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration.
Okamoto T; Yamada T; Kuno A; Ogawa K; Tang M; Sano H; Ohara H; Nakao H; Kataoka H; Shirai T; Itoh M
Pancreas; 2005 Apr; 30(3):e64-70. PubMed ID: 15782091
[TBL] [Abstract][Full Text] [Related]
20. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
Ma LJ; Jha S; Ling H; Pozzi A; Ledbetter S; Fogo AB
Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
